|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Aegerion Pharmaceuticals, Inc. (AEGR) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
31,480,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$1.97 - $1.97 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Fraser Craig |
Pres., US/Int. Comm. & Manuf. |
|
2013-11-01 |
4 |
AS |
$82.28 |
$187,275 |
D/D |
(2,250) |
0 |
|
- |
|
Fraser Craig |
Pres., US/Int. Comm. & Manuf. |
|
2013-11-01 |
4 |
OE |
$13.01 |
$29,273 |
D/D |
2,250 |
2,250 |
|
- |
|
Beer Marc D |
Chief Executive Officer |
|
2013-10-30 |
4 |
AS |
$84.15 |
$3,511,665 |
D/D |
(40,000) |
195,726 |
|
- |
|
Beer Marc D |
Chief Executive Officer |
|
2013-10-30 |
4 |
OE |
$1.54 |
$61,600 |
D/D |
40,000 |
235,726 |
|
- |
|
Smith Sandford D |
Director |
|
2013-10-29 |
4 |
AS |
$95.00 |
$237,690 |
D/D |
(2,502) |
0 |
|
- |
|
Smith Sandford D |
Director |
|
2013-10-29 |
4 |
OE |
$15.00 |
$37,530 |
D/D |
2,502 |
2,502 |
|
- |
|
Sumeray Mark |
Chief Medical Officer |
|
2013-10-15 |
4 |
AS |
$79.95 |
$160,659 |
D/D |
(2,000) |
0 |
|
- |
|
Sumeray Mark |
Chief Medical Officer |
|
2013-10-15 |
4 |
OE |
$13.01 |
$26,020 |
D/D |
2,000 |
2,000 |
|
- |
|
Sumeray Mark |
Chief Medical Officer |
|
2013-10-07 |
4 |
AS |
$92.37 |
$326,086 |
D/D |
(3,500) |
0 |
|
- |
|
Sumeray Mark |
Chief Medical Officer |
|
2013-10-07 |
4 |
OE |
$13.01 |
$45,535 |
D/D |
3,500 |
3,500 |
|
- |
|
Fraser Craig |
Pres., US/Int. Comm. & Manuf. |
|
2013-10-07 |
4 |
AS |
$92.40 |
$1,863,146 |
D/D |
(20,000) |
0 |
|
- |
|
Fraser Craig |
Pres., US/Int. Comm. & Manuf. |
|
2013-10-07 |
4 |
OE |
$13.01 |
$260,200 |
D/D |
20,000 |
20,000 |
|
- |
|
Sumeray Mark |
Chief Medical Officer |
|
2013-09-16 |
4 |
AS |
$88.50 |
$179,549 |
D/D |
(2,000) |
0 |
|
- |
|
Sumeray Mark |
Chief Medical Officer |
|
2013-09-16 |
4 |
OE |
$13.01 |
$26,020 |
D/D |
2,000 |
2,000 |
|
- |
|
Perceptive Life Sciences Master Fund Ltd |
10% Owner |
|
2013-09-05 |
4 |
S |
$89.20 |
$66,900,000 |
I/I |
(750,000) |
2,823,426 |
|
- |
|
Beer Marc D |
Chief Executive Officer |
|
2013-09-03 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,335 |
195,726 |
|
- |
|
Scheer David |
Director |
|
2013-08-21 |
4 |
S |
$84.57 |
$1,691,638 |
I/I |
(20,000) |
620,154 |
|
- |
|
Sumeray Mark |
Chief Medical Officer |
|
2013-08-16 |
4 |
AS |
$88.01 |
$177,413 |
D/D |
(2,000) |
0 |
|
- |
|
Sumeray Mark |
Chief Medical Officer |
|
2013-08-16 |
4 |
OE |
$13.01 |
$26,020 |
D/D |
2,000 |
2,000 |
|
- |
|
Beer Marc D |
Chief Executive Officer |
|
2013-08-15 |
4 |
AS |
$87.08 |
$5,312,209 |
D/D |
(60,000) |
199,061 |
|
- |
|
Beer Marc D |
Chief Executive Officer |
|
2013-08-15 |
4 |
OE |
$1.54 |
$92,400 |
D/D |
60,000 |
259,061 |
|
- |
|
Fitzpatrick Mark J. |
Chief Financial Officer |
|
2013-08-14 |
4 |
AS |
$92.74 |
$700,816 |
D/D |
(7,500) |
500 |
|
- |
|
Fitzpatrick Mark J. |
Chief Financial Officer |
|
2013-08-14 |
4 |
OE |
$17.64 |
$132,300 |
D/D |
7,500 |
8,000 |
|
- |
|
Smith Sandford D |
Director |
|
2013-08-12 |
4 |
S |
$92.25 |
$141,791 |
D/D |
(1,537) |
0 |
|
- |
|
Smith Sandford D |
Director |
|
2013-08-09 |
4 |
S |
$92.33 |
$781,414 |
D/D |
(8,463) |
1,537 |
|
- |
|
251 Records found
|
|
Page 4 of 11 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|